產(chǎn)品供應(yīng)紅霉素

  • 發(fā)布日期：2022-12-27
  • 有效期限：30天
湖北康明德醫(yī)藥化工有限公司 VIP
204-040-1
C37H67NO13
733.9268
詳細(xì)信息
  • Erythromycin
  • ;Abomacetin;Ak-Mycin;Aknin;Drmysin;E-Base;E.E.S;Emgel;EMU;E-mycin;Ergel;Eritocina;Eritrocina;Erthrogran;Eryacne;ERYC;Erycen;Erycette;Erycin;Erycinum;Ery Derm;Erymax;ERY-PED;ERY-TAB;Erythro;Erythroguent;Erythromast;Erythromast 36;Erythromid;Ilocap;Ilosone;Ilotycin;Inderm;L-alpha-Egg-phosphatidylcholine;P.C.E.;Pediamycin;Retcin;Robimycin;Statcin;Staticin;Stiemycin;Torlamicina;Torlamicna;T-Stat;Wintrocin;Wyamycin-s;6-{[4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name);(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name);(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name);(2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl propanoate (non-preferred name);(2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name);(3R,7R,9R,11R,13S,14R)-6-{[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name);abboticin;
  • InChI=1/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21?,22-,23+,24+,25-,26+,28-,29?,30?,31+,32?,34?,35-,36-,37-/m1/s1
  • 1.2g/cm3
  • 138-140℃
  • 818.4°C at 760 mmHg
  • 448.8°C

  • 熔點(diǎn)：138 - 140

  • 紅霉素 英文名稱(chēng) Erythromycin 中文別名 紅霉素肟 CAS RN 114-07-8 EINECS號(hào) 204-040-1 分 子 式 C37H67NO13 分 子 量 733.9268 危險(xiǎn)品標(biāo)志 Xn:Harmful 風(fēng)險(xiǎn)術(shù)語(yǔ) R42/43; 安全術(shù)語(yǔ) S24; S37; S45; 物化性質(zhì) 熔點(diǎn)：138 - 140 用　　途 本品為大環(huán)內(nèi)酯類(lèi)抗生素衍生物中間體屬抑菌型抗生素，抗菌譜與青菌素相似
  • 產(chǎn)品規(guī)格：藥典

免責(zé)聲明：以上所展示的信息由企業(yè)自行提供，內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布企業(yè)負(fù)責(zé)，化工網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。我們?cè)瓌t上建議您選擇化工網(wǎng)高級(jí)會(huì)員或VIP會(huì)員。